Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are a standard treatment for certain advanced breast cancers, but their side effects can disrupt daily life. These drugs may cause adverse effects that require management.
Three CDK4/6 inhibitors have received approval: palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio). While they share many side effects, patients often tolerate one better than the others. Common issues include low blood counts, fatigue, joint pain, nausea, vomiting, diarrhea, hair thinning, nail changes, and raised liver enzymes.
How these drugs affect the body
CDK4/6 inhibitors work by pausing cancer cell growth, though they can also impact healthy cells. White blood cells may decrease, a condition known as neutropenia. Unlike chemotherapy, which destroys these cells, CDK4/6 inhibitors only temporarily stop their production.
Related: Sub-Q Breast Cancer Treatments Effective as IV
For ribociclib and palbociclib, which follow a three-weeks-on, one-week-off schedule, white blood cells typically recover during the off-week. This pattern lowers infection risk compared to continuous suppression. Blood counts are checked regularly: every two weeks for the first eight weeks, then every four weeks for four months, and later every eight to 12 weeks.
Taking medication at night may help manage fatigue. Some patients find this timing aligns with their natural sleep cycle.
“I often recommend patients take the medications at night so if they are fatigued, it may actually help with sleep,” said Margaret Gatti-Mays, MD, MPH, breast medical oncology section chief at The Ohio State University Full Cancer Center. She added that this approach depends on the individual.
Managing gastrointestinal side effects
Abemaciclib frequently causes diarrhea in patients with advanced hormone receptor-positive (HR+), HER2-negative breast cancer. Dr. Gatti-Mays recommends using anti-diarrheal medications like Imodium or Lomotil right away if symptoms continue. Standard dosing instructions may not apply to cancer patients, and some may need higher doses under medical supervision.
Related: ASH releases new guidelines for AYA ALL care
Diet changes can also help. Dr. Gatti-Mays suggests starting with bland foods, such as the “BRAT” diet—bananas, rice, applesauce, and toast—before slowly adding other foods back. Most gastrointestinal side effects, including abdominal pain, nausea, and vomiting, usually improve after two to three months of treatment.
If side effects become difficult to handle, dose reductions may help. Dr. Gatti-Mays explained that lowering the dose can ease symptoms without reducing the drug’s effectiveness. For diarrhea, this adjustment often provides relief while keeping treatment benefits intact.
Patients sometimes worry when side effects appear early. Many symptoms become more manageable over time, and small changes—like timing, diet, or dosage—can make a difference. Keeping the care team informed ensures proper monitoring and intervention when needed.
Leave a Reply